Fungus Used to Synthesize Titanium Dioxide Nanoparticles

Researchers successfully created titanium dioxide nanoparticles using the fungal strain Penicillium chrysogenum.

Updated on Oct. 21, 2026 in Life Sciences

Isometric editorial illustration showing spherical nanoparticles clustered within organic fungal filaments, representing green synthesis of medical-grade materials.
Researchers have successfully synthesized titanium dioxide nanoparticles using the fungal strain Penicillium chrysogenum, offering a sustainable new method for therapeutic material production. AI Illustration. Upload story photo >

Scientists have synthesized titanium dioxide nanoparticles using the endophytic fungus Penicillium chrysogenum as a biocatalyst. The resulting particles demonstrated significant antimicrobial, antioxidant, and anticancer properties in laboratory testing.

Why it matters

This green synthesis method offers a sustainable way to produce metal-oxide nanoparticles with potential applications in medicine and therapeutic research. These findings highlight the role of fungal metabolites in creating advanced functional materials.

Characterization was conducted using techniques including TEM, FT-IR, EDX, and XRD to confirm the anatase crystalline structure. The study utilized GC-MS to identify active fungal metabolites such as alkaloids, terpenoids, and steroids.

The players

Penicillium chrysogenum

This is a species of fungus known for its role in the biosynthesis of various chemical compounds and its use as a biocatalyst in laboratory settings.

The details

The synthesized nanoparticles exhibit a spherical morphology measuring between 10 and 40 nm. EDX analysis confirmed an elemental composition of 44.1% titanium and 15.32% oxygen, with a measured zeta potential of -28.42.

Timeline

  1. October 21, 2026: The research results were published.

The Big Picture

This study advances the field of green synthesis by utilizing fungal-derived biocatalysts for metal-oxide production. The research demonstrates a paradigm shift toward biological manufacturing processes that replace traditional chemical reduction methods.

This development could eventually lead to the creation of more biocompatible therapeutic agents for cancer treatment. Such innovations might improve the effectiveness of targeted drug delivery systems in future clinical settings.

The takeaway

Using fungal metabolites allows for the creation of nanoparticles without the need for harsh, toxic chemical precursors. Researchers believe these specific particles show promise for further exploration in combating various bacterial and fungal strains.

Further reading

For more on emerging research in this field, visit Life Sciences.

Source note: This article includes information reported by Nature.